Spectral AI FY2025 EPS Estimate Increased by Zacks Small Cap

Spectral AI, Inc. (NASDAQ:MDAI) – Equities researchers at Zacks Small Cap lifted their FY2025 EPS estimates for shares of Spectral AI in a research note issued on Wednesday, April 2nd. Zacks Small Cap analyst J. Vandermosten now forecasts that the company will earn ($0.45) per share for the year, up from their prior forecast of ($0.57). The consensus estimate for Spectral AI’s current full-year earnings is ($0.48) per share. Zacks Small Cap also issued estimates for Spectral AI’s FY2026 earnings at ($0.18) EPS and FY2026 earnings at ($0.18) EPS.

Separately, HC Wainwright reissued a “buy” rating and issued a $3.50 price objective on shares of Spectral AI in a research note on Wednesday.

Spectral AI Price Performance

MDAI opened at $1.21 on Friday. The business has a 50 day moving average price of $1.69 and a two-hundred day moving average price of $1.67. The company has a market capitalization of $28.13 million, a price-to-earnings ratio of -1.86 and a beta of 0.62. Spectral AI has a 1-year low of $0.82 and a 1-year high of $3.25.

Spectral AI (NASDAQ:MDAI) last issued its quarterly earnings results on Thursday, March 27th. The company reported ($0.06) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.07. The company had revenue of $7.60 million during the quarter, compared to analyst estimates of $6.83 million.

Hedge Funds Weigh In On Spectral AI

Several hedge funds have recently made changes to their positions in MDAI. Avantax Planning Partners Inc. lifted its stake in Spectral AI by 44.7% during the fourth quarter. Avantax Planning Partners Inc. now owns 231,336 shares of the company’s stock valued at $655,000 after purchasing an additional 71,484 shares during the last quarter. Renaissance Technologies LLC bought a new position in shares of Spectral AI in the fourth quarter valued at $272,000. Jane Street Group LLC acquired a new stake in shares of Spectral AI during the 4th quarter valued at $92,000. Millington Financial Advisors LLC bought a new stake in shares of Spectral AI during the 4th quarter worth $85,000. Finally, Northern Trust Corp acquired a new position in shares of Spectral AI in the 4th quarter worth $44,000. Institutional investors and hedge funds own 67.08% of the company’s stock.

About Spectral AI

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.